Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypoparathyroidism | 35 | 2024 | 136 | 11.970 |
Why?
|
Parathyroid Hormone | 34 | 2024 | 1803 | 3.850 |
Why?
|
Hypocalcemia | 10 | 2024 | 200 | 2.270 |
Why?
|
Parathyroid Glands | 7 | 2024 | 518 | 1.820 |
Why?
|
Calcium | 28 | 2024 | 5722 | 1.460 |
Why?
|
Hormone Replacement Therapy | 8 | 2021 | 751 | 1.240 |
Why?
|
Hyperparathyroidism, Primary | 6 | 2022 | 163 | 1.190 |
Why?
|
Diphtheria Toxin | 2 | 2017 | 253 | 1.010 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 7 | 2024 | 305 | 0.980 |
Why?
|
Hypercalciuria | 2 | 2017 | 31 | 0.980 |
Why?
|
GTP-Binding Protein alpha Subunits | 2 | 2017 | 102 | 0.950 |
Why?
|
Nephrocalcinosis | 1 | 2022 | 52 | 0.820 |
Why?
|
Phosphates | 7 | 2023 | 770 | 0.790 |
Why?
|
Hyperphosphatemia | 2 | 2017 | 38 | 0.670 |
Why?
|
Fibrous Dysplasia, Polyostotic | 3 | 2024 | 39 | 0.670 |
Why?
|
Vitamin D | 15 | 2023 | 3303 | 0.670 |
Why?
|
Parathyroidectomy | 4 | 2017 | 242 | 0.660 |
Why?
|
Calcitriol | 6 | 2024 | 296 | 0.660 |
Why?
|
Recombinant Proteins | 8 | 2021 | 6534 | 0.600 |
Why?
|
Periodicals as Topic | 2 | 2018 | 1463 | 0.550 |
Why?
|
Naphthalenes | 1 | 2017 | 198 | 0.520 |
Why?
|
Databases as Topic | 1 | 2018 | 473 | 0.520 |
Why?
|
Peptides, Cyclic | 2 | 2017 | 392 | 0.500 |
Why?
|
Receptors, Parathyroid Hormone | 5 | 1999 | 332 | 0.490 |
Why?
|
Hypophosphatemia, Familial | 2 | 2012 | 32 | 0.460 |
Why?
|
Osteogenesis Imperfecta | 1 | 2014 | 81 | 0.450 |
Why?
|
Hajdu-Cheney Syndrome | 1 | 2013 | 2 | 0.440 |
Why?
|
Editorial Policies | 1 | 2018 | 458 | 0.430 |
Why?
|
Glucose Transporter Type 2 | 1 | 2012 | 61 | 0.410 |
Why?
|
Receptor, Notch2 | 1 | 2013 | 87 | 0.410 |
Why?
|
Osteoporosis | 4 | 2022 | 1606 | 0.410 |
Why?
|
Fanconi Syndrome | 1 | 2012 | 34 | 0.410 |
Why?
|
Rickets | 1 | 2012 | 70 | 0.390 |
Why?
|
Fractures, Bone | 3 | 2023 | 2046 | 0.380 |
Why?
|
Calcium, Dietary | 4 | 2022 | 529 | 0.380 |
Why?
|
Fibroblast Growth Factors | 6 | 2023 | 867 | 0.370 |
Why?
|
Collagen Type I | 1 | 2014 | 616 | 0.370 |
Why?
|
Osteomalacia | 3 | 2008 | 60 | 0.360 |
Why?
|
Genes, Dominant | 3 | 2013 | 852 | 0.360 |
Why?
|
Bone and Bones | 7 | 2023 | 2568 | 0.350 |
Why?
|
Parathyroid Neoplasms | 1 | 2011 | 242 | 0.340 |
Why?
|
Information Dissemination | 1 | 2018 | 1126 | 0.330 |
Why?
|
Gene Deletion | 2 | 2014 | 2665 | 0.320 |
Why?
|
Germ-Line Mutation | 2 | 2013 | 1858 | 0.290 |
Why?
|
Parathyroid Hormone-Related Protein | 3 | 2015 | 327 | 0.290 |
Why?
|
Nuclear Proteins | 3 | 2012 | 5799 | 0.280 |
Why?
|
Receptors, G-Protein-Coupled | 4 | 2022 | 1252 | 0.280 |
Why?
|
Pedigree | 7 | 2014 | 4542 | 0.260 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2023 | 58 | 0.260 |
Why?
|
Hypercalcemia | 4 | 2024 | 423 | 0.240 |
Why?
|
Fascioliasis | 2 | 2000 | 14 | 0.230 |
Why?
|
Mutation | 6 | 2017 | 30053 | 0.230 |
Why?
|
Fasciola hepatica | 2 | 2000 | 15 | 0.230 |
Why?
|
Transcription Factors | 4 | 2014 | 12130 | 0.230 |
Why?
|
Humans | 70 | 2024 | 761596 | 0.230 |
Why?
|
Fibrous Dysplasia of Bone | 1 | 2024 | 53 | 0.220 |
Why?
|
Bone Density Conservation Agents | 2 | 2023 | 795 | 0.220 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18255 | 0.210 |
Why?
|
Amiloride | 1 | 2022 | 116 | 0.210 |
Why?
|
Ovulation Induction | 1 | 2024 | 277 | 0.200 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2023 | 2242 | 0.200 |
Why?
|
Homeostasis | 5 | 2023 | 3323 | 0.200 |
Why?
|
Hyperparathyroidism | 3 | 2018 | 337 | 0.190 |
Why?
|
Urolithiasis | 1 | 2022 | 125 | 0.190 |
Why?
|
Endocrine System Diseases | 1 | 2023 | 249 | 0.180 |
Why?
|
Adenoma | 1 | 2011 | 2163 | 0.180 |
Why?
|
Female | 36 | 2024 | 392705 | 0.180 |
Why?
|
Anthelmintics | 1 | 2000 | 83 | 0.170 |
Why?
|
Homozygote | 2 | 2015 | 1776 | 0.170 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2024 | 497 | 0.170 |
Why?
|
Minerals | 1 | 2021 | 283 | 0.170 |
Why?
|
Male | 33 | 2024 | 360846 | 0.160 |
Why?
|
Adult | 20 | 2024 | 221210 | 0.160 |
Why?
|
Receptors, Calcium-Sensing | 2 | 2018 | 318 | 0.160 |
Why?
|
Mice, Transgenic | 3 | 2017 | 9542 | 0.150 |
Why?
|
Thyroidectomy | 3 | 2023 | 908 | 0.150 |
Why?
|
Chromogranins | 1 | 2019 | 161 | 0.150 |
Why?
|
Animals | 25 | 2024 | 168475 | 0.150 |
Why?
|
DNA Mutational Analysis | 5 | 2019 | 4111 | 0.150 |
Why?
|
Puberty, Precocious | 1 | 2019 | 164 | 0.150 |
Why?
|
Cholestasis | 1 | 2000 | 378 | 0.140 |
Why?
|
Osteoporotic Fractures | 1 | 2022 | 411 | 0.140 |
Why?
|
Brain | 1 | 2024 | 27121 | 0.140 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2019 | 195 | 0.140 |
Why?
|
Luminescent Agents | 1 | 2017 | 29 | 0.140 |
Why?
|
Neuralgia | 1 | 2024 | 615 | 0.140 |
Why?
|
Middle Aged | 20 | 2024 | 220921 | 0.140 |
Why?
|
Poisons | 1 | 2017 | 38 | 0.140 |
Why?
|
Glucuronidase | 1 | 2018 | 202 | 0.140 |
Why?
|
Kidney | 9 | 2023 | 7048 | 0.130 |
Why?
|
Hyponatremia | 1 | 2019 | 279 | 0.130 |
Why?
|
Depsipeptides | 1 | 2016 | 95 | 0.130 |
Why?
|
Mutation, Missense | 2 | 2015 | 2571 | 0.130 |
Why?
|
Gene Knock-In Techniques | 1 | 2017 | 421 | 0.130 |
Why?
|
Bone Density | 3 | 2024 | 3551 | 0.120 |
Why?
|
Benzimidazoles | 1 | 2000 | 858 | 0.120 |
Why?
|
Mesenchymoma | 2 | 2008 | 49 | 0.120 |
Why?
|
Diabetes Insipidus, Neurogenic | 1 | 2014 | 20 | 0.120 |
Why?
|
Treatment Outcome | 7 | 2024 | 64685 | 0.120 |
Why?
|
Authorship | 1 | 2018 | 284 | 0.120 |
Why?
|
Peer Review, Research | 1 | 2018 | 340 | 0.120 |
Why?
|
Bradykinin | 1 | 1995 | 208 | 0.120 |
Why?
|
Acrylic Resins | 1 | 1995 | 135 | 0.120 |
Why?
|
Calcium Citrate | 1 | 2013 | 8 | 0.110 |
Why?
|
Uremia | 4 | 1996 | 201 | 0.110 |
Why?
|
Quality of Life | 5 | 2022 | 13367 | 0.110 |
Why?
|
Molecular Sequence Data | 7 | 2012 | 17635 | 0.110 |
Why?
|
Mice | 9 | 2023 | 81539 | 0.110 |
Why?
|
Pseudohypoparathyroidism | 3 | 2019 | 87 | 0.110 |
Why?
|
Renal Dialysis | 3 | 2008 | 1796 | 0.110 |
Why?
|
Amino Acid Sequence | 4 | 2012 | 13446 | 0.110 |
Why?
|
Spasm | 1 | 2013 | 130 | 0.110 |
Why?
|
Double-Blind Method | 3 | 2018 | 12341 | 0.110 |
Why?
|
Lanthanum | 1 | 2012 | 30 | 0.100 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2012 | 14 | 0.100 |
Why?
|
Finger Phalanges | 1 | 2013 | 41 | 0.100 |
Why?
|
Genetic Diseases, Inborn | 1 | 1997 | 604 | 0.100 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2012 | 44 | 0.100 |
Why?
|
HEK293 Cells | 3 | 2017 | 4281 | 0.100 |
Why?
|
Chromatin | 1 | 2024 | 2961 | 0.100 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 962 | 0.100 |
Why?
|
Glucose Transporter Type 1 | 1 | 2012 | 186 | 0.100 |
Why?
|
Injections, Subcutaneous | 1 | 2013 | 681 | 0.100 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4740 | 0.100 |
Why?
|
Polyamines | 1 | 2012 | 133 | 0.100 |
Why?
|
Aged | 10 | 2024 | 169310 | 0.090 |
Why?
|
Reference Values | 1 | 2018 | 4920 | 0.090 |
Why?
|
Acetates | 1 | 2012 | 321 | 0.090 |
Why?
|
Chelating Agents | 1 | 2012 | 387 | 0.090 |
Why?
|
Heterozygote | 2 | 2019 | 2787 | 0.090 |
Why?
|
Family Health | 2 | 2012 | 1257 | 0.090 |
Why?
|
Europe | 1 | 2017 | 3420 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3801 | 0.090 |
Why?
|
Kidney Tubules, Proximal | 1 | 2012 | 383 | 0.090 |
Why?
|
Green Fluorescent Proteins | 1 | 2016 | 2065 | 0.090 |
Why?
|
Tissue Extracts | 2 | 2008 | 141 | 0.090 |
Why?
|
Hyperparathyroidism, Secondary | 2 | 2004 | 125 | 0.090 |
Why?
|
Genes, Recessive | 1 | 2012 | 623 | 0.080 |
Why?
|
Bone Marrow Cells | 1 | 2017 | 2417 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2022 | 4415 | 0.080 |
Why?
|
Genetic Linkage | 2 | 2013 | 2341 | 0.080 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2008 | 36 | 0.080 |
Why?
|
Diphosphonates | 2 | 2023 | 635 | 0.080 |
Why?
|
Dietary Supplements | 2 | 2018 | 3415 | 0.080 |
Why?
|
Xenopus laevis | 1 | 2012 | 963 | 0.080 |
Why?
|
Angiodysplasia | 1 | 2008 | 22 | 0.080 |
Why?
|
Hemangiopericytoma | 1 | 2008 | 71 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 1995 | 1516 | 0.070 |
Why?
|
Jaw Neoplasms | 1 | 2008 | 70 | 0.070 |
Why?
|
Cell Lineage | 1 | 2017 | 2557 | 0.070 |
Why?
|
Creatinine | 2 | 2023 | 1899 | 0.070 |
Why?
|
Oocytes | 1 | 2012 | 1166 | 0.070 |
Why?
|
Adolescent | 6 | 2024 | 88326 | 0.070 |
Why?
|
Thigh | 1 | 2008 | 241 | 0.070 |
Why?
|
Amino Acid Substitution | 3 | 2019 | 1739 | 0.070 |
Why?
|
Leg Ulcer | 1 | 2007 | 71 | 0.070 |
Why?
|
Kidney Failure, Chronic | 3 | 2008 | 2472 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2332 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1642 | 0.070 |
Why?
|
Chickens | 1 | 2008 | 859 | 0.070 |
Why?
|
Nose Neoplasms | 1 | 2008 | 249 | 0.070 |
Why?
|
Models, Molecular | 2 | 2013 | 5439 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 3713 | 0.060 |
Why?
|
Registries | 1 | 2021 | 8225 | 0.060 |
Why?
|
Headache | 1 | 2013 | 1256 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2014 | 12973 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4878 | 0.060 |
Why?
|
Calciphylaxis | 1 | 2007 | 130 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2022 | 7859 | 0.060 |
Why?
|
COS Cells | 2 | 2015 | 1130 | 0.060 |
Why?
|
Calcium Channel Agonists | 1 | 2004 | 26 | 0.060 |
Why?
|
Sodium Fluoride | 1 | 2024 | 65 | 0.060 |
Why?
|
Foot | 1 | 2008 | 575 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2015 | 2091 | 0.060 |
Why?
|
Physicians | 1 | 2021 | 4591 | 0.050 |
Why?
|
DNA | 2 | 2014 | 7213 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20568 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6312 | 0.050 |
Why?
|
Genome-Wide Association Study | 2 | 2013 | 12690 | 0.050 |
Why?
|
Facial Bones | 1 | 2024 | 208 | 0.050 |
Why?
|
Base Sequence | 4 | 2012 | 12441 | 0.050 |
Why?
|
Diabetic Foot | 1 | 2007 | 380 | 0.050 |
Why?
|
Osteomyelitis | 1 | 2007 | 407 | 0.050 |
Why?
|
Young Adult | 3 | 2013 | 59260 | 0.050 |
Why?
|
Mice, Knockout | 1 | 1997 | 14417 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6965 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2018 | 58984 | 0.050 |
Why?
|
Alendronate | 1 | 2022 | 175 | 0.050 |
Why?
|
Neoplasms | 2 | 2008 | 22173 | 0.050 |
Why?
|
Indocyanine Green | 1 | 2023 | 233 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2022 | 15633 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4243 | 0.040 |
Why?
|
Renin | 1 | 2022 | 641 | 0.040 |
Why?
|
Receptors, Calcitriol | 1 | 2022 | 360 | 0.040 |
Why?
|
Diabetic Nephropathies | 1 | 2007 | 973 | 0.040 |
Why?
|
Acetaminophen | 1 | 2023 | 555 | 0.040 |
Why?
|
Sweden | 1 | 2022 | 1379 | 0.040 |
Why?
|
NAD | 1 | 2023 | 614 | 0.040 |
Why?
|
Glycolysis | 1 | 2023 | 835 | 0.040 |
Why?
|
Receptors, Virus | 1 | 2022 | 640 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22174 | 0.040 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 1998 | 127 | 0.040 |
Why?
|
Photoaffinity Labels | 1 | 1998 | 85 | 0.040 |
Why?
|
CHO Cells | 2 | 2016 | 1387 | 0.040 |
Why?
|
Comorbidity | 1 | 2012 | 10508 | 0.040 |
Why?
|
Aldosterone | 1 | 2022 | 870 | 0.040 |
Why?
|
Republic of Korea | 1 | 2019 | 590 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1132 | 0.040 |
Why?
|
Imidazoles | 1 | 2023 | 1180 | 0.040 |
Why?
|
Hypophosphatemia | 1 | 2018 | 92 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2016 | 3792 | 0.040 |
Why?
|
Family | 1 | 2008 | 3195 | 0.040 |
Why?
|
Down-Regulation | 2 | 1995 | 2919 | 0.040 |
Why?
|
Genetic Variation | 1 | 2012 | 6567 | 0.040 |
Why?
|
Cricetinae | 2 | 2016 | 2423 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36426 | 0.030 |
Why?
|
RNA, Messenger | 5 | 2018 | 12794 | 0.030 |
Why?
|
Genomic Imprinting | 1 | 1998 | 329 | 0.030 |
Why?
|
Peptide Fragments | 2 | 1999 | 5112 | 0.030 |
Why?
|
Prospective Studies | 4 | 2024 | 54423 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2022 | 1738 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2023 | 1170 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2021 | 1440 | 0.030 |
Why?
|
Estrogens | 1 | 2022 | 1522 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2018 | 878 | 0.030 |
Why?
|
Binding Sites | 2 | 2016 | 6056 | 0.030 |
Why?
|
Cohort Studies | 2 | 2022 | 41495 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2016 | 147 | 0.030 |
Why?
|
Cross-Linking Reagents | 1 | 1998 | 687 | 0.030 |
Why?
|
RANK Ligand | 1 | 2017 | 318 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1998 | 1693 | 0.030 |
Why?
|
Chronic Disease | 2 | 2021 | 9319 | 0.030 |
Why?
|
Hyperplasia | 1 | 2018 | 1152 | 0.030 |
Why?
|
Cellulose | 1 | 1995 | 118 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2024 | 2650 | 0.030 |
Why?
|
Cricetulus | 1 | 2016 | 814 | 0.030 |
Why?
|
Integrases | 1 | 2017 | 518 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2018 | 616 | 0.030 |
Why?
|
Adipogenesis | 1 | 2017 | 368 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2019 | 2927 | 0.030 |
Why?
|
Proteins | 2 | 1999 | 6032 | 0.030 |
Why?
|
Denmark | 1 | 2016 | 771 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 1 | 2024 | 2400 | 0.030 |
Why?
|
Child | 3 | 2024 | 80158 | 0.030 |
Why?
|
Membranes, Artificial | 1 | 1995 | 366 | 0.030 |
Why?
|
Cell Count | 1 | 2017 | 1835 | 0.030 |
Why?
|
Calcium Compounds | 1 | 2012 | 38 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2008 | 18966 | 0.030 |
Why?
|
Skull | 1 | 2017 | 818 | 0.030 |
Why?
|
Mutagenesis | 1 | 2016 | 1232 | 0.030 |
Why?
|
United States | 2 | 2017 | 72340 | 0.020 |
Why?
|
Sulfones | 1 | 1995 | 448 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2548 | 0.020 |
Why?
|
Genetic Engineering | 1 | 1997 | 933 | 0.020 |
Why?
|
Kidney Calculi | 1 | 2016 | 463 | 0.020 |
Why?
|
Osteoblasts | 1 | 2017 | 1143 | 0.020 |
Why?
|
Ligands | 1 | 1998 | 3272 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1997 | 4174 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2007 | 3407 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39106 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3076 | 0.020 |
Why?
|
Protein Conformation | 1 | 1998 | 3968 | 0.020 |
Why?
|
Siblings | 1 | 2014 | 825 | 0.020 |
Why?
|
Signal Transduction | 3 | 2017 | 23447 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2016 | 809 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16592 | 0.020 |
Why?
|
Adipocytes | 1 | 2017 | 1194 | 0.020 |
Why?
|
Cataract | 1 | 2016 | 832 | 0.020 |
Why?
|
Ultrasonography | 2 | 2019 | 5971 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 42232 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 21355 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2022 | 80647 | 0.020 |
Why?
|
Rats | 4 | 1998 | 23741 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 2012 | 902 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6484 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6864 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2012 | 2748 | 0.020 |
Why?
|
Polymers | 1 | 1995 | 1616 | 0.020 |
Why?
|
Anaphylaxis | 1 | 1995 | 757 | 0.020 |
Why?
|
Models, Genetic | 1 | 1997 | 3442 | 0.020 |
Why?
|
Rats, Wistar | 3 | 1996 | 1848 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5821 | 0.020 |
Why?
|
Pressure Ulcer | 1 | 2007 | 157 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 10212 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4244 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2022 | 7391 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2508 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2017 | 3313 | 0.020 |
Why?
|
Health Status | 1 | 2018 | 4077 | 0.010 |
Why?
|
Blotting, Western | 1 | 2012 | 5035 | 0.010 |
Why?
|
Liver | 1 | 2000 | 7528 | 0.010 |
Why?
|
Citrates | 1 | 2004 | 134 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9610 | 0.010 |
Why?
|
Algorithms | 1 | 2024 | 14033 | 0.010 |
Why?
|
Cell Line | 2 | 2012 | 15601 | 0.010 |
Why?
|
Molecular Probes | 2 | 1995 | 309 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10721 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 29890 | 0.010 |
Why?
|
Leg | 1 | 2007 | 1088 | 0.010 |
Why?
|
Opossums | 1 | 2001 | 104 | 0.010 |
Why?
|
Cholangiography | 1 | 2000 | 181 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9353 | 0.010 |
Why?
|
Paraneoplastic Syndromes | 1 | 2001 | 155 | 0.010 |
Why?
|
Bile Ducts | 1 | 2000 | 282 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8633 | 0.010 |
Why?
|
Molecular Weight | 1 | 2001 | 2186 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15733 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1997 | 11904 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2008 | 22176 | 0.010 |
Why?
|
Ischemia | 1 | 2007 | 1884 | 0.010 |
Why?
|
Lod Score | 1 | 1998 | 600 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2001 | 1541 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2001 | 1463 | 0.010 |
Why?
|
Odds Ratio | 1 | 2008 | 9647 | 0.010 |
Why?
|
Obesity, Morbid | 1 | 2007 | 1277 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12059 | 0.010 |
Why?
|
Hot Temperature | 1 | 2001 | 1440 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 1998 | 951 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12463 | 0.010 |
Why?
|
Urine | 1 | 1995 | 362 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1995 | 1302 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 6131 | 0.010 |
Why?
|
Transfection | 1 | 2001 | 5774 | 0.010 |
Why?
|
Blood | 1 | 1995 | 596 | 0.010 |
Why?
|
Haplotypes | 1 | 1998 | 2713 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1998 | 4615 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2001 | 7593 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2007 | 12149 | 0.000 |
Why?
|
Risk Factors | 1 | 2008 | 74213 | 0.000 |
Why?
|